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A major question in studying adult neurogenesis is the source and identity of molecules that regulate stem
cells. In this issue of Neuron, Delgado et al. (2014) uncover that endothelial-derived NT-3 acts as a mediator
of quiescence in the V-SVZ adult neural stem cell niche.Neural stem cells persist in specialized
niches in the adult mammalian brain.
Stem cells in the ventricular/subventricu-
lar zone (V/SVZ), also known as the sube-
pendymal zone (SEZ), which is located
adjacent to the lateral ventricles, give
rise to neurons that migrate to the olfac-
tory bulb (Figure 1A). Interestingly, V/
SVZ stem cells share ultrastructural and
molecular features of astrocytes. Upon
activation, glial fibrillary acidic protein
(GFAP)-positive quiescent neural stem
cells (qNSCs) upregulate markers of pro-
liferation, as well as epidermal growth fac-
tor receptor (EGFR) and nestin (Codega
et al., 2014). They then generate rapidly
dividing transit-amplifying cells, which in
turn give rise to neuroblasts that migrate
to the olfactory bulb (Figure 1B). A small
number of oligodendrocytes are also
generated in the V/SVZ.
The adult V/SVZ stem cell niche is
complex. Two essential compartments
are the cerebrospinal fluid (CSF) and a
specialized vasculature. V/SVZ stem cells
(B1 cells) have an elongated radial
morphology and span all compartments
of the niche. The apical process of B1
cells contacts the CSF, which flows
dynamically through the lateral ventricles.
The primary source of the CSF is the
choroid plexus, a highly vascularized
miniorgan that floats in each ventricle.
B1 cells also extend a long basal process
that contacts the planar vascular plexus in
the SVZ (Figure 1A). As such, B1 stem
cells are exposed to diverse signals,
including cell-cell and extracellular matrix
interactions, and diffusible signals fromdifferent sources, which they integrate
to regulate their behavior (reviewed in
Silva-Vargas et al., 2013). How different
niche compartments affect each stage of
the stem cell lineage is just beginning to
emerge.
Recent work has highlighted that the
quiescent state is actively maintained.
Cell adhesion plays a key role in neural
stem cell quiescence. Disrupting cell-cell
or cell-ECM contacts leads to increased
proliferation of neural stem cells (reviewed
in Silva-Vargas et al., 2013). In addition, li-
gands present in the CSF, such as S1P
and PGD2, also actively maintain stem
cell quiescence (Codega et al., 2014). In
contrast, diffusible signals from endothe-
lial cells, including SDF1 and PEDF, pro-
mote the proliferation of activated stem
cells and transit-amplifying cells (re-
viewed in Silva-Vargas et al., 2013). In
this issue of Neuron, Delgado et al.
(2014) show a novel role for endothelial-
derived neurotrophin-3 (NT-3), a member
of the neurotrophin family classically
associated with cell survival, in mediating
neural stem cell quiescence in the adult
neurogenic niche.
High levels of NT-3 are made by
discrete populations of neurons and as-
trocytes in the nervous system. Delgado
et al. (2014) show that NT-3 is also pro-
duced, at lower levels, by brain endothe-
lial cells and by the microvasculature in
the choroid plexus. Notably, NT-3 protein
is also found in the CSF. Conditional dele-
tion of NT-3 in endothelial cells leads to
the loss of NT-3 protein in both the V/
SVZ and CSF, confirming that endothelialNeuron 8cells are a major source of NT-3 in V/SVZ
stem cell niche. B1 cells and ependymal
cells do not synthesize NT-3. B1 cells
express both TrkB and TrkC receptors,
but not TrkA, and take NT-3 up from the
microenvironment.
To functionally assess the role of NT-3,
Delgado et al. (2014) used several ap-
proaches to manipulate NT-3 levels. First,
they investigated proliferation in B1 cells
in young adult (60-day-old) heterozygous
NT-3 mutants and found that the propor-
tion of dividing GFAP+ B1 cells, as well
as of label retaining cells, is increased,
with no change in the total proportion of
GFAP+ cells. This increase was accom-
panied by higher numbers of olfactory
bulb neurons and significant changes in
olfactory behavior. An increase in oligo-
dendrocyte formation was also observed.
However, fate-mapping studies will be
needed to dissect whether the changes
in oligodendrocyte formation are due to
increased stem cell proliferation or alter-
natively to increased proliferation of
NG2+ progenitors in the corpus callosum
due to local changes in NT-3 in the white
matter (Kahn et al., 1999).
Delgado et al. (2014) also examined
neurosphere formation as a functional
in vitro assay to assess stem cells. In het-
erozygous NT-3 mice, an increased num-
ber of neurospheres formed as compared
to wild-type mice, with no change in the
size of individual neurospheres, consis-
tent with an expanded pool of actively
dividing cells in vivo that give rise to neu-
rospheres (Pastrana et al., 2011). The
same effect was observedwhen SVZ cells3, August 6, 2014 ª2014 Elsevier Inc. 507
CSF
CSF
N
T-
3
NT-3
Nitrergic 
neurons
TACaNSCqNSC NB
A
CSF/ PerivascularIntermediateSVZ
M
id
dl
e 
A
ge
d
NS formation
B1 cell proliferation in vivo
LRC
NeurogenesisYo
un
g
Normal SVZ 
aNSC
NT-3 
deficient
qNSC
NT-3
CSF
NT-3
CSF
NS formation
B1 cell proliferation in vivo
LRC
Neurogenesis
CSF
NS FORMATION
Decreased NT-3
TAC
WT
CP
B1
B1
GFAP+
GFAP+
Nestin+
EGFR+
Nestin+EGFR+
Blood
Vessel
B
C
E
Ependymal
N
T-
3
N
T-
3
qNSC 
recruitment
 
cycling rate / mode of division
B1 cell
NT-3 NT-3
TrKC
eNOS
Cell cycle
NO
NO NO
D
p
eNOS
Figure 1. Effect of NT3 on V/SVZ Stem Cells
(A) Cell types and V/SVZ niche compartments. Schema of coronal hemi-section of adult mouse brain
showing V/SVZ (orange) adjacent to the lateral ventricle (light orange). The choroid plexus (CP) is the pri-
Neuron
Previews
508 Neuron 83, August 6, 2014 ª2014 Elsevier Inc.were cultured with conditioned medium
from endothelial cells or in transwells
with primary brain endothelial cells in
which NT-3 was conditionally deleted
from endothelial cells using Tie2-Cre as
a driver. Conversely, NT-3 treatment of
wild-type SVZ cells decreased neuro-
sphere formation and was reversed by
blocking with TrkC antibodies.
Interestingly, after the initial proliferative
burst in young adult mice, in heterozy-
gous NT-3 middle-aged mice (240 days
old), neurosphere formation and LRCs
both decreased, suggesting that over
time, B1 stem cells become depleted. At
this time point, there was also an increase
in GFAP+S100+ cells, suggesting that
increased astrocytic differentiation might
be occurring as well. Altogether, these re-
sults elegantly demonstrate that endothe-
lial-derived NT-3, either from the V/SVZ
vasculature or in the CSF, exerts a cyto-
static effect in the SVZ stem cell niche.
How are the effects of endothelial-
derived NT-3 mediated? Nitric oxide
(NO) is a gaseous signaling molecule
that is synthesized by the enzyme nitric
oxide synthase (NOS), which catalyzes
the conversion of L-arginine and oxygen
into citrulline and NO. There are three
isoforms of NOS in the brain, neuronal
NOS (nNOS), endothelial NOS (eNOS),
and inducible NOS. nNOS is expressed
by nitrergic neurons in close proximity to
the SVZ (Figure 1A). Under physiological
conditions, NO inhibits proliferation in
adult neurogenic niches in both SVZ and
SGZ but after injury has the opposite ef-
fect and increases proliferation (Estrada
and Murillo-Carretero, 2005; Berg et al.,
2013). In pulmonary and brain vascula-
ture, NT-3 regulates the levels of eNOS.
Delgado et al. (2014) therefore hypothe-
sized that the production of NO could
be mediating the cytostatic effect ofmary source of CSF. NT-3 is made by endothelial
cells and is also present in the CSF (pink). Quies-
cent B1 (dark blue) and activated B1 stem cells
(turquoise), transit-amplifying cells (green), neuro-
blasts (red), and ependymal cells (gray) all closely
interact in the niche.
(B) Stem cell lineage and markers.
(C) Summary of Delgado et al. (2014)’s findings of
decreased NT-3 in the V/SVZ stem cell niche.
(D) Proposed mechanism of NT-3 regulation via
eNOS in B1 cells.
(E) Possible effects of NT-3 on the V/SVZ stem cell
lineage.
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combination of genetic and pharmaco-
logical approaches in their coculture
system of endothelial and SVZ cells. L-
NAME, a general NOS inhibitor, increased
neurosphere formation by SVZ cells co-
cultured with endothelial cells; this effect
was reversed by cotreatment with NT-3.
In contrast, treatment with an nNOS-spe-
cific inhibitor had no effect. By mixing
and matching SVZ cells and endothe-
lial cells of opposite eNOS genotypes
(mutant or wild-type eNOS), they showed
that eNOS acts cell autonomously in SVZ
cells and that in SVZ cells, eNOS is rapidly
phosphorylated, leading to an increased
synthesis of NO upon NT-3 treatment
or culture with endothelial conditioned
medium. Finally, Delgado et al. (2014)
confirmed that CSF-borne NT-3 could ac-
cess B1 cells. In vivo infusion of NT-3 into
the lateral ventricle decreased prolifera-
tion of GFAP+ cells in vivo and rescued
the increased proliferation in Ntf3-Tie2ko
mice, but had no effect when infused
into the lateral ventricle of eNOS mutant
mice. Together, these experiments show
that endothelial-derived NT-3 acts as a
cytostatic factor for SVZ cells via an
eNOS-dependent pathway.
Into the Future
Delgado et al. (2014) clearly demonstrate
that endothelial-derived NT-3 inhibits
proliferation of GFAP+ B1 cells in vivo
and decreases neurosphere formation
in vitro. However, although widely used,
neurospheres are not an ideal readout of
in vivo stem cells (Pastrana et al., 2011).
First, both EGFR+-activated neural stem
cells and transit-amplifying cells give rise
to neurospheres. Moreover, new fluores-
cence-activated cell sorting (FACS) purifi-
cation strategies have recently allowed
the prospective isolation of quiescent
neural stem cells for the first time (Codega
et al., 2014; Mich et al., 2014). In contrast
to aNSCs, qNSCs largely do not give rise
to neurospheres but only do so upon
activation and upregulation of EGFR andnestin (Codega et al., 2014; Figure 1B).
Interestingly, NO inhibits both EGFR and
PI3K signaling in SVZ cells (Torroglosa
et al., 2007). As such, in the future, it will
be very important to use FACS-purified
populations instead of bulk SVZ cells to
define the effect of NT-3 and other niche
factors on each stage in the stem cell
lineage, including qNSCs, aNSCs, and
transit-amplifying cells both in vivo and
in vitro, given the key role of EGFR in
this region. Indeed, this will allow the pre-
cise dissection of whether NT-3 is acting
to increase neurosphere formation by (1)
recruiting more quiescent neural stem
cells to an activated state (light blue) that
are able to form neurospheres, (2) chang-
ing the proliferation rates or modes of
division (filled ovals) of aNSCs, thereby
increasing their capacity to form neuro-
spheres, and/or (3) changing the pro-
liferation rates or modes of division of
transit-amplifying cells (green-filled ovals)
to increase their neurosphere formation
(Figure 1E). Nitrergic neurons adjacent to
the SVZ also synthesize NO and affect
SVZ proliferation (Estrada and Murillo-
Carretero, 2005). As such, there are two
different sources of NO, local neurons
and the stem cells themselves (and prob-
ably transit-amplifying cells), highlighting
the complexity of NO signaling in the
niche. How these two NO-mediated path-
ways are integrated and whether they
signal via different downstream cascades
under different physiological conditions
will be important to further explore.
The CSF is a complex reservoir of sig-
nals from multiple sources, including sys-
temic factors that may dynamically reflect
the physiological state of the animal
(Silva-Vargas et al., 2013). In the embryo,
the CSF contains many proliferation sig-
nals (Lehtinen et al., 2011). In the adult,
the CSF has been proposed to promote
quiescence and the vasculature pro-
liferation. The present paper by Delgado
et al. (2014) shows that the endothelial
compartment also contributes to main-
taining quiescence in the adult SVZ stemNeuron 8cell niche. Given the regional heterogene-
ity among adult neural stem cells (Krieg-
stein and Alvarez-Buylla 2009), as well
as in the niche, it will be very interesting
to determine whether the effect of NT-3,
or other niche factors, is selective for a
regional subset of V/SVZ stem cells, how
regional differences in the niche impact
in vivo regulation, and how these both
change during aging.
The cellular andmolecular dissection of
the contribution of different niche com-
partments to adult neural stem cell regula-
tion is ready to be cracked open and will
illuminate how diffusible and contact
mediated signals from the vascular niche,
cerebrospinal fluid, and other niche ele-
ments are integrated and eventually can
be harnessed for brain repair.
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